Skip to main content
Premium Trial:

Request an Annual Quote

Tobira Therapeutics Taps Pharsight's PKS Online to Support HIV Drug Development

Premium

Pharsight, a St. Louis, Mo.-based software firm, said this week that Tobira Therapeutics has selected PKS Online to support its HIV drug development efforts.

Tobira will use the software to analyze, manage, and report data for its HIV drug candidate cenicriviroc, an antagonist of both CCR5, a co-receptor that’s required for HIV infection, and CCR2, a co-receptor that is involved in a number of metabolic and cardiovascular diseases. The drug is currently in Phase 2 clinical development.

David Martin, Tobira's senior vice president of drug development and regulatory affairs, said that PKS Online "[eliminates] the need for deployment, validation, and management of an in-house system."

"With PKS Online, I have real-time visibility and streamlined access to time-critical analyses and study results, available on my desktop, to readily share with our management team, scientific advisors, and other key stakeholders," he said in a statement.

PKS Online is a software-as-a-service implementation of Pharsight Knowledgebase Server, an enterprise data management system for storing and tracking pharmacokinetic and pharmacodynamic data and analyses.

Among other features, the system lets users export studies in the Clinical Data Interchange Standards Consortium format for regulatory submission as well as simplify data-management tasks required to create multi-study analyses and prepare pharmacometric models.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.